Applied Biosystems gets $24.5 million Defense Department contract

By Elaine Rigoli

Tampa, Fla., Aug. 9 - Applied Biosystems, an Applera Corp. business, announced that the Department of Defense has awarded the company a $24.5 million contract to accelerate the development of a prototype instrument system that is intended to improve the way infectious diseases are identified for epidemiological and biosecurity purposes.

Upon completion, the company said this system will offer results in less than one hour following sample processing by providing a streamlined workflow and the ability to analyze multiple pathogen targets in a single test.

Last month, Applied Biosystems presented key components of the prototype to the U.S. Air Force, which will be responsible for validating the next-generation pathogen identification system.

The current technologies that are used to test for infectious pathogens typically reside in a centralized laboratory environment.

By developing a prototype system that simplifies the processing and analysis of pathogen detection tests, Applied Biosystems said it will enable a new generation of decentralized molecular detection systems that can be deployed in more diverse locations and operated by a broader range of public health and safety professionals.

Applied Biosystems, based in Foster City, Calif., develops instrument-based systems, consumables, software and services for new pharmaceuticals.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.